Friday, April 9, 2010

4/10 RegenMD

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future.
RegenMD Feed My Inbox

Knoepfler Blog Added to Links
April 9, 2010 at 9:52 AM

 

The promotion of endothelial progenitor cells recruitment by nerve growth factors in tissue-engineered blood vessels.
April 9, 2010 at 8:20 AM

Related Articles

The promotion of endothelial progenitor cells recruitment by nerve growth factors in tissue-engineered blood vessels.

Biomaterials. 2010 Mar;31(7):1636-45

Authors: Zeng W, Yuan W, Li L, Mi J, Xu S, Wen C, Zhou Z, Xiong J, Sun J, Ying D, Yang M, Li X, Zhu C

Endothelial progenitor cells (EPCs) mobilization and homing are critical to the development of an anti-thrombosis and anti-stenosis tissue-engineered ! blood vessel. The growth and activation of blood vessels are supported by nerves. We investigated whether nerve growth factors (NGF) can promote EPCs mobilization and endothelialization of tissue-engineered blood vessels. In vitro, NGF promoted EPCs to form more colonies, stimulated human EPCs to differentiate into endothelial cells, and significantly enhanced EPCs migration. Flow cytometric analysis revealed that NGF treatment increased the number of EPCs in the peripheral circulation of C57BL/6 mice. Furthermore, the treatment of human EPCs with NGF facilitated their homing into wire-injured carotid arteries after injection into mice. Decellularized rat blood vessel matrix was incubated with EDC cross-linked collagen and bound to NGF protein using the bifunctional coupling agent N-succinmidyl3-(2-pyridyldit-hio) propionate (SPDP). The NGF-bound tissue-engineered blood vessel was implanted into rat carotid artery for 1 week and 1 month. NGF-bound blood vessels possessed si! gnificantly higher levels of endothelialization and patency th! an contr ols did. These results demonstrated that NGF can markedly increase EPCs mobilization and homing to vascular grafts. Neurotrophic factors such as NGF have a therapeutic potential for the construction of tissue-engineered blood vessels in vivo.

PMID: 20006381 [PubMed - indexed for MEDLINE]

 

This email was sent to regenmd@gmail.comAccount Login
Don't want to receive this feed any longer? Unsubscribe here
This email was carefully delivered by Feed My Inbox. 230 Franklin Road Suite 814 Franklin, TN 37064

No comments: